Aurora Cannabis (ACB) Earnings Date, Estimates & Call Transcripts $5.61 -0.11 (-1.92%) (As of 09/23/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryLatest Earnings DateAug. 7ConfirmedActual EPS (Aug. 7) -$0.11 Beat By $0.24 Consensus EPS (Aug. 7) -$0.35 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide Deck Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueACB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ACB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Chaikin Analytics320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shiftGet the strange truth from a 50-year Wall Street insider… including the name and ticker of the stock Aurora Cannabis Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241($0.11)($0.11)($0.11) Q2 20241($0.04)($0.04)($0.04) Q4 20241($0.30)($0.30)($0.30) 20243($0.45)($0.45)($0.45) Q1 20252($0.20)($0.02)($0.11) Q2 20252($2.10)$0.02($1.04) Q3 20252($1.90)$0.00($0.95) Q4 20252($1.30)$0.04($0.63) FY 20258($5.50)$0.04 ($2.73)ACB Earnings Date and InformationAurora Cannabis last released its quarterly earnings results on August 7th, 2024. The reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.35) by $0.24. The firm had revenue of $67.27 million for the quarter, compared to the consensus estimate of $55.98 million. Aurora Cannabis has generated ($1.40) earnings per share over the last year (($1.40) diluted earnings per share). Earnings for Aurora Cannabis are expected to grow in the coming year, from ($1.12) to ($0.23) per share. Read More Aurora Cannabis Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/7/2024Q1 2025($0.35)($0.11)+$0.24($0.32)$55.98 million$67.27 million 6/20/2024Q4 2024($0.18)$0.11+$0.29$0.52$51.28 million$49.98 million 2/8/2024Q3 2024($0.10)($0.20)($0.10)-$45.94 million$53.34 million 11/9/2023Q2 2024($0.50)($0.50)-($0.09)$46.58 million$52.54 million 8/10/2023Q1 2024($0.80)($0.40)+$0.40($0.02)$46.80 million$55.92 million 6/14/2023Q3 2023($0.40)($1.50)($1.10)($0.12)$47.89 million$47.35 million Sell NVDA Now? (Ad)Hundreds of hedge funds are fleeing this stock A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shiftGet the strange truth from a 50-year Wall Street insider… including the name and ticker of the stock2/9/2023Q2 2023($0.70)($1.40)($0.70)($0.13)$42.60 million$50.95 million 11/10/2022Q1 2023($0.90)($0.80)+$0.10($0.03)$38.85 million$37.77 million 9/20/2022Q4 2022($1.20)($0.80)+$0.40$1.87$39.23 million$39.35 million 5/12/2022Q3 2022($1.60)($10.40)($8.80)$1.65$40.58 million$39.82 million 2/10/2022Q2 2022($1.70)($4.20)($2.50)($0.54)$45.87 million$48.07 million 11/9/2021Q1 2022($1.80)($0.90)+$0.90($0.13)$47.84 million$47.74 million 9/27/2021Q4 2021($2.20)($2.10)+$0.10$0.13$45.91 million$44.63 million 5/12/2021Q1 2021($1.70)($8.20)($6.50)$0.19$55.17 million$43.56 million 2/11/2021Q2 2021($1.90)($2.80)($0.90)$0.78$54.66 million$51.93 million11/14/2020Q3 2020($2.40)($9.20)($6.80)($0.59)$48.07 million$50.90 million 9/24/2020Q4 2020($3.00)($1.30)+$1.70$11.78$54.39 million$52.02 million5/14/2020Q3 2020($5.30)($7.40)($2.10)($0.46)$46.93 million$56.31 million2/13/2020Q2 2020($7.20)($21.60)($14.40)$0.53$47.24 million$42.45 million11/14/2019Q3 2019($3.60)$1.20+$4.80$0.01$72.82 million$57.02 million Aurora Cannabis Earnings - Frequently Asked Questions When did Aurora Cannabis announce their last quarterly earnings? Aurora Cannabis (NASDAQ:ACB) last announced its quarterly earning data on Wednesday, August 7, 2024. Learn more on ACB's earnings history. Did Aurora Cannabis beat their earnings estimates last quarter? In the previous quarter, Aurora Cannabis (NASDAQ:ACB) reported ($0.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.35) by $0.24. Learn more on analysts' earnings estimate vs. ACB's actual earnings. How can I listen to Aurora Cannabis's earnings conference call? The conference call for Aurora Cannabis's latest earnings report can be listened to online. Listen to Conference Call How can I read Aurora Cannabis's conference call transcript? The conference call transcript for Aurora Cannabis's latest earnings report can be read online. Read Transcript How much revenue does Aurora Cannabis generate each year? Aurora Cannabis (NASDAQ:ACB) has a recorded annual revenue of $278.98 million. How much profit does Aurora Cannabis generate each year? Aurora Cannabis (NASDAQ:ACB) has a recorded net income of -$48.62 million. ACB has generated -$1.40 earnings per share over the last four quarters. What is Aurora Cannabis's EPS forecast for next year? Aurora Cannabis's earnings are expected to grow from ($1.12) per share to ($0.23) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Spyre Therapeutics Earnings Results Gyre Therapeutics Earnings Results Calliditas Therapeutics AB (publ) Earnings Results Disc Medicine Earnings Results Arcutis Biotherapeutics Earnings Results Travere Therapeutics Earnings Results Prothena Earnings Results Phathom Pharmaceuticals Earnings Results CARGO Therapeutics Earnings Results Praxis Precision Medicines Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:ACB) was last updated on 9/23/2024 by MarketBeat.com Staff From Our PartnersElection Shocker: Trump Won't See This ComingIf you suspect Democrats will play dirty games in this election… You are RIGHT! Executive Order 14019 ha...Banyan Hill Publishing | SponsoredInvesting Legend Warns: “Disturbing Event Is Coming to America”America Repeats Act That's Destroyed Stock Markets For 200 Years The Fed has now repeated a mistake that ce...Stansberry Research | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe $15 Stock Powering NVIDIA, TESLA and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known suppl...Behind the Markets | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Aurora Cannabis Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
